Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hiltunen

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Circulation|April 8, 1998
Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion developmentT P Hiltunen, J S Luoma, T Nikkari, et al.
Journal of Clinical Epidemiology|September 29, 2001
Prevalence of disability in three birth cohorts at old age over time spans of 10 and 20 yearsI Winblad, M Jääskeläinen, S L Kivelä, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 14, 2011
STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive menKati M Donner, Timo P Hiltunen, Tuula Hannila-Handelberg, et al.
European Journal of Endocrinology|October 19, 2012
Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1Kati M Donner, Timo P Hiltunen, Olli A Jänne, et al.
American Journal of Hypertension|December 6, 2008
Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES studyTimo Suonsyrjä, Tuula Hannila-Handelberg, Heidi Fodstad, et al.
Atherosclerosis|February 13, 2001
Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptorT P Hiltunen, P J Gough, D R Greaves, et al.
Pharmacogenetics and Genomics|March 20, 2010
Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatmentTimo Suonsyrjä, Kati Donner, Tuula Hannila-Handelberg, et al.
Pharmacogenomics|March 28, 2018
Effect of hydrochlorothiazide on serum uric acid concentration: a genome-wide association studyEero M Ala-Mutka, Jenni M Rimpelä, Frej Fyhrquist, et al.
Plos One|November 10, 2017
Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertensionTimo P Hiltunen, Jenni M Rimpelä, Robert P Mohney, et al.
Archives of Physical Medicine and Rehabilitation|December 29, 2000
Domains and determinants of quality of life after stroke caused by brain infarctionM L Kauhanen, J T Korpelainen, P Hiltunen, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Circulation|April 8, 1998
Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion developmentT P Hiltunen, J S Luoma, T Nikkari, et al.
Journal of Clinical Epidemiology|September 29, 2001
Prevalence of disability in three birth cohorts at old age over time spans of 10 and 20 yearsI Winblad, M Jääskeläinen, S L Kivelä, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 14, 2011
STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive menKati M Donner, Timo P Hiltunen, Tuula Hannila-Handelberg, et al.
European Journal of Endocrinology|October 19, 2012
Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1Kati M Donner, Timo P Hiltunen, Olli A Jänne, et al.
American Journal of Hypertension|December 6, 2008
Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES studyTimo Suonsyrjä, Tuula Hannila-Handelberg, Heidi Fodstad, et al.
Atherosclerosis|February 13, 2001
Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptorT P Hiltunen, P J Gough, D R Greaves, et al.
Pharmacogenetics and Genomics|March 20, 2010
Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatmentTimo Suonsyrjä, Kati Donner, Tuula Hannila-Handelberg, et al.
Pharmacogenomics|March 28, 2018
Effect of hydrochlorothiazide on serum uric acid concentration: a genome-wide association studyEero M Ala-Mutka, Jenni M Rimpelä, Frej Fyhrquist, et al.
Plos One|November 10, 2017
Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertensionTimo P Hiltunen, Jenni M Rimpelä, Robert P Mohney, et al.
Archives of Physical Medicine and Rehabilitation|December 29, 2000
Domains and determinants of quality of life after stroke caused by brain infarctionM L Kauhanen, J T Korpelainen, P Hiltunen, et al.
Pageof 6